EDP-167

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameEDP-167
Drug Alias NameEDP167EDP-167
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiopoietin like 3 modulators
TargetsAngiopoietin like 3
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEteng Pharmaceutical (Zhuhai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesEteng Pharmaceutical (Zhuhai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemiaDyslipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A